Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Actor Daniel Dae Kim's Convalescent Plasma Donation at Vitalant Featured on 'The Call to Unite' Live Streamed Event

Vitalant Logo (PRNewsfoto/Vitalant)

News provided by

Vitalant

May 02, 2020, 07:30 ET

Share this article

Share toX

Share this article

Share toX

SCOTTSDALE, Ariz., May 2, 2020 /PRNewswire/ -- Actor Daniel Dae Kim's convalescent plasma donation was featured May 1 on 'The Call to Unite'—a 24-hour live streamed event that celebrates our shared humanity during the coronavirus pandemic. Special Olympics chairman Tim Shriver organized the event, which showcases celebrities like Kim, Oprah and Julia Roberts, alongside former presidents and faith leaders.

After fully recovering from COVID-19, Kim flew from his home in Hawaii to give his vital plasma donation at a Vitalant blood donation center in Ventura, CA. Convalescent plasma contains antibodies that are active against the disease to give patients' immune systems the ability to attack the virus.

"I learned about the Mayo Clinic being named the national program for this effort and I wanted to do my part to help those who are still battling the illness," said Daniel Dae Kim. "I hope those who can will consider joining me to help other Americans in need—either through the Mayo Clinic, Red Cross or their local blood donation center, like Vitalant." Kim plays a doctor in the TV shows The Good Doctor and New Amsterdam and was also on Lost and Hawaii Five-O.

Visual assets can be downloaded at https://drive.google.com/drive/folders/1CRYTz_Eq4LlEGgNNgzB1BjJibs4z_YEG?usp=sharing

In early April, Vitalant, the nation's largest, independent nonprofit blood service provider, launched a program in collaboration with hospital partners, the Mayo Clinic and the American Red Cross to treat COVID-19 patients with convalescent plasma. The Food and Drug Administration (FDA) has identified and approved convalescent plasma treatment as an "emergency investigational new drug." It is currently the only antibody treatment available to COVID-19 patients and, as such, is a promising new treatment option.

Kim announced on Instagram March 19 that he had tested positive for COVID-19 after returning to his home in Hawaii from a work trip in New York. He soon developed a sore throat, chest tightness, body aches and a fever. He was diagnosed with COVID-19 after going to a drive-through testing clinic in Honolulu. For the next several weeks, Kim self-isolated at his home to protect his family while receiving treatment remotely from his physician.

"This disease is unlike anything I've ever experienced," said Kim. "Now that I've recovered, my plasma may contain antibodies that will help people who are fighting COVID-19 right now. I'm glad I'm able to help those who are still fighting their own battles."

Currently, there are no vaccines or proven treatments for COVID-19 because the virus is so new. Although trials for a vaccine are underway, it is expected to be many months before one is approved.

"Our hearts go out to those who have suffered from the disease or lost loved ones. Daniel is setting a great example for those who have recovered. Donating convalescent plasma holds the additional promise of helping a critically ill COVID-19 patient turn the corner," said Cliff Numark, Vitalant's chief of marketing. "This procedure complements what is needed every day: blood donations help patients for a variety of reasons—from surviving trauma, to undergoing chemotherapy to receiving an organ transplant."

Vitalant is seeking convalescent plasma donors to help patients. Eligibility criteria are:

  • Prior diagnosis of COVID-19, documented by a laboratory test or a positive serological test for the SARS-CoV-2 antibodies, taken after recovery
  • Complete resolution of symptoms for at least 14 days
  • Meet all other current FDA donor eligibility requirements to donate plasma

Even with these requirements, there may be additional tests or other criteria required. In some instances, those who have recovered from COVID-19 may be able to donate, even if they did not have an initial laboratory test. Those who meet the above criteria and want to donate plasma are encouraged to apply through the Vitalant website Vitalant.org/covidfree. For more information, please call 866-CV-PLSMA (866-287-5762).

"As this life-transforming program continues to expand, we encourage those who have recovered from COVID-19 to visit our website and complete the application form," Numark added. "It's an easy first step toward helping patients battling this devastating disease."

Vitalant will only accept donors who meet all FDA-required donor eligibility criteria and are symptom-free for at least 14 days. Potential donors can only donate if they have applied and have been accepted to the program. Donors cannot walk in for this procedure; they must complete the form at Vitalant.org/covidfree to begin the application process. Potential donors will then be contacted by Vitalant.

About Vitalant
Vitalant ("Vye-TAL-ent") is a national community blood service provider, supplying comprehensive transfusion medicine services for nearly 1,000 hospitals and health care partners for patients in need across 40 states. Vitalant inspires local communities to serve the needs of others and transform lives through the selfless act of donating blood. Every day, almost 5,000 blood donations are needed to meet the needs of people throughout the country, and Vitalant's 800,000 donors supply 1.8 million donations a year. In addition to blood products, Vitalant offers customers transfusion services, medical consulting, quality guidance, ongoing education, research and more. For more information and to schedule a donation, visit vitalant.org or call 877-25-VITAL (877-258-4825). Join the conversation about impacting the lives of others on Facebook, Twitter and Instagram.

CONTACTS:
Carol Brugman
(602) 568-9156
[email protected]

Chandra Stewart
(602) 315-0043
[email protected]

SOURCE Vitalant

Related Links

https://www.vitalant.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

More Blood Donors Needed to Be a Match for Sickle Cell Patients

More Blood Donors Needed to Be a Match for Sickle Cell Patients

September is Sickle Cell Awareness Month and nonprofit blood provider Vitalant wants to remind everyone how vital donating blood is to meet the...

Vitalant Offering Blood Donors a Free A1C Check in September

Vitalant Offering Blood Donors a Free A1C Check in September

This September, nonprofit Vitalant is, for the first time, offering blood donors an extra check on their health while they help save and improve the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Infection Control

Infection Control

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.